Publication: National feasibility survey of peritoneal dialysis key performance indicators in Thailand from provider perspective
1
Issued Date
2020-06-01
Resource Type
ISSN
14401797
13205358
13205358
Other identifier(s)
2-s2.0-85074079415
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Nephrology. Vol.25, No.6 (2020), 483-490
Suggested Citation
Krit Pongpirul, Talerngsak Kanjanabuch, Pongpratch Puapatanakul, Piyatida Chuengsaman, Phongsak Dandecha, Pornchai Kingwatanakul, Suchai Sritippayawan, Anutra Chittinandana, Somchai Eiam-Ong, Kriengsak Vareesangthip, Kriang Tungsanga National feasibility survey of peritoneal dialysis key performance indicators in Thailand from provider perspective. Nephrology. Vol.25, No.6 (2020), 483-490. doi:10.1111/nep.13668 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/56233
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
National feasibility survey of peritoneal dialysis key performance indicators in Thailand from provider perspective
Abstract
© 2019 Asian Pacific Society of Nephrology Background: Peritoneal dialysis (PD) has been the main method of renal replacement therapy under the “PD First” policy in Thailand since 2008. Initially, the proposed 13 key performance indicators (KPIs) raised feasibility concerns because of inequitable distribution of resources such as laboratory facilities and/or specialized health-care staff for PD care throughout the country. Methods: Data availability and goals from the health-care providers' perspective were explored using an online questionnaire survey for all PD centers registered with the Nephrology Society of Thailand from May to June 2016. The availability of essential data required for each KPI indicator to achieve the desired target was assessed using a 5-point Likert scale. Results: Of the 197 centers, 119 responded to the survey (response rate of 60.41%). PD indicators with a high percentage of strongly disagree or disagree were “PD adequacy measured in the last 12 months” (26.83%), “Total weekly Kt/V ≥ 1.7” (24.59%), “3-year PD technique survival” (21.31%), “Serum parathyroid levels within 150 to 500 pg/mL” (16.94%), and a “3-year PD patient survival” (19.01%). As many as 34.17%, 39.19%, 27.27%, 28.93%, and 22.00%, respectively, did not anticipate that the targets could be achieved. Based on the findings from this survey, the national committee concluded that these indicators be removed, and only eight PD indicators were launched. Conclusion: Given the importance of KPIs for quality assurance and financial reimbursement, inputs from health-care providers especially data availability and achievement of targets should be considered to ensure feasibility before the final list of indicators are launched.